Optima Health (AIM:OPT), the UK's leading provider of technology enabled corporate health and wellbeing solutions, issued an unaudited full-year trading update ahead of the publication of results for the year ended 31 March.
Revenue for the year was approximately £121.0 million, up 15% year‑on‑year (FY25: £105.0 million), and the Group recognised other income of £4.7 million relating to a previously disclosed procurement matter, with management saying top-line performance is in line with market expectations.
"We are building momentum as we deliver against our strategic objectives," said Jonathan Thomas, Chief Executive Officer of Optima Health.
The Group completed the transformational acquisition of PAM Healthcare on 26 March for approximately £100.0 million, and integration is proceeding to plan with £1.3 million of annualised cost synergies delivered as of 1 June and further revenue and operational synergies expected.
New business annualised wins were £10.8 million in FY26 for Optima only (FY25: £27.2 million), the enlarged group reports a strong pipeline including PAM, net debt excluding leases stood at £94.4 million as at 31 March, and the company reiterated its medium‑term targets of £200 million revenue and £40 million adjusted EBITDA while expecting to report full-year results in August 2026.
